| Year |
Citation |
Score |
| 2024 |
Al-Attar R, Jargstorf J, Romagnuolo R, Jouni M, Alibhai FJ, Lampe PD, Solan JL, Laflamme MA. Casein Kinase 1 Phosphomimetic Mutations Negatively Impact Connexin-43 Gap Junctions in Human Pluripotent Stem Cell-Derived Cardiomyocytes. Biomolecules. 14. PMID 38254663 DOI: 10.3390/biom14010061 |
0.449 |
|
| 2023 |
Bannerman D, Pascual-Gil S, Campbell S, Jiang R, Wu Q, Okhovatian S, Wagner KT, Montgomery M, Laflamme MA, Davenport Huyer L, Radisic M. Itaconate and citrate releasing polymer attenuates foreign body response in biofabricated cardiac patches. Materials Today. Bio. 24: 100917. PMID 38234461 DOI: 10.1016/j.mtbio.2023.100917 |
0.319 |
|
| 2023 |
Zhuang K, Romagnuolo R, Sadikov Valdman T, Vollett KDW, Szulc DA, Cheng HM, Laflamme MA, Cheng HM. Bright ferritin for long-term MR imaging of human embryonic stem cells. Stem Cell Research & Therapy. 14: 330. PMID 37964388 DOI: 10.1186/s13287-023-03565-4 |
0.378 |
|
| 2022 |
Yang D, Gomez-Garcia J, Funakoshi S, Tran T, Fernandes I, Bader GD, Laflamme MA, Keller GM. Modeling human multi-lineage heart field development with pluripotent stem cells. Cell Stem Cell. 29: 1382-1401.e8. PMID 36055193 DOI: 10.1016/j.stem.2022.08.007 |
0.521 |
|
| 2022 |
Wulkan F, Romagnuolo R, Qiang B, Laflamme MA. Methods for Transepicardial Cell Transplantation in a Swine Myocardial Infarction Model. Methods in Molecular Biology (Clifton, N.J.). 2485: 191-212. PMID 35618907 DOI: 10.1007/978-1-0716-2261-2_13 |
0.512 |
|
| 2022 |
Dhahri W, Sadikov Valdman T, Wilkinson D, Pereira E, Ceylan E, Andharia N, Qiang B, Masoudpour H, Wulkan F, Quesnel E, Jiang W, Funakoshi S, Mazine A, Gomez-Garcia MJ, Latifi N, ... ... Laflamme MA, et al. In Vitro Matured Human Pluripotent Stem Cell-derived Cardiomyocytes Form Grafts With Enhanced Structure and Function in Injured Hearts. Circulation. PMID 35089805 DOI: 10.1161/CIRCULATIONAHA.121.053563 |
0.582 |
|
| 2021 |
Gomez-Garcia MJ, Quesnel E, Al-Attar R, Laskary AR, Laflamme MA. Maturation of human pluripotent stem cell derived cardiomyocytes in vitro and in vivo. Seminars in Cell & Developmental Biology. PMID 34053865 DOI: 10.1016/j.semcdb.2021.05.022 |
0.554 |
|
| 2021 |
Funakoshi S, Fernandes I, Mastikhina O, Wilkinson D, Tran T, Dhahri W, Mazine A, Yang D, Burnett B, Lee J, Protze S, Bader GD, Nunes SS, Laflamme M, Keller G. Generation of mature compact ventricular cardiomyocytes from human pluripotent stem cells. Nature Communications. 12: 3155. PMID 34039977 DOI: 10.1038/s41467-021-23329-z |
0.58 |
|
| 2021 |
Filice D, Dhahri W, Solan JL, Lampe PD, Steele E, Milani N, Van Biber B, Zhu WZ, Valdman TS, Romagnuolo R, Otero-Cruz JD, Hauch KD, Kay MW, Sarvazyan N, Laflamme MA. Correction to: Optical mapping of human embryonic stem cell-derived cardiomyocyte graft electrical activity in injured hearts. Stem Cell Research & Therapy. 12: 66. PMID 33461574 DOI: 10.1186/s13287-020-02077-9 |
0.481 |
|
| 2020 |
Haller C, Friedberg MK, Laflamme MA. The role of regenerative therapy in the treatment of right ventricular failure: a literature review. Stem Cell Research & Therapy. 11: 502. PMID 33239066 DOI: 10.1186/s13287-020-02022-w |
0.458 |
|
| 2020 |
Filice D, Dhahri W, Solan JL, Lampe PD, Steele E, Milani N, Van Biber B, Zhu WZ, Valdman TS, Romagnolo R, Otero-Cruz JD, Hauch KD, Kay MW, Sarvazyan N, Laflamme MA. Optical mapping of human embryonic stem cell-derived cardiomyocyte graft electrical activity in injured hearts. Stem Cell Research & Therapy. 11: 417. PMID 32988411 DOI: 10.1186/s13287-020-01919-w |
0.508 |
|
| 2020 |
Sun X, Wu J, Qiang B, Romagnuolo R, Gagliardi M, Keller G, Laflamme MA, Li RK, Nunes SS. Transplanted microvessels improve pluripotent stem cell-derived cardiomyocyte engraftment and cardiac function after infarction in rats. Science Translational Medicine. 12. PMID 32967972 DOI: 10.1126/scitranslmed.aax2992 |
0.551 |
|
| 2020 |
Robbins ER, Pins GD, Laflamme MA, Gaudette GR. Creation of a Contractile Biomaterial From a Decellularized Spinach Leaf Without ECM Protein Coating: An in vitro study. Journal of Biomedical Materials Research. Part A. PMID 32323417 DOI: 10.1002/Jbm.A.36971 |
0.358 |
|
| 2019 |
Smith A, Choi E, Gray K, Macadangdang J, Ahn EH, Clark EC, Laflamme M, Wu JC, Murry CE, Tung L, Kim DH. NanoMEA: a tool for high-throughput, electrophysiological phenotyping of patterned excitable cells. Nano Letters. PMID 31845810 DOI: 10.1021/Acs.Nanolett.9B04152 |
0.47 |
|
| 2019 |
Romagnuolo R, Masoudpour H, Porta-Sánchez A, Qiang B, Barry J, Laskary A, Qi X, Massé S, Magtibay K, Kawajiri H, Wu J, Valdman Sadikov T, Rothberg J, Panchalingam KM, Titus E, ... ... Laflamme MA, et al. Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate the Infarcted Pig Heart but Induce Ventricular Tachyarrhythmias. Stem Cell Reports. PMID 31056479 DOI: 10.1016/J.Stemcr.2019.04.005 |
0.632 |
|
| 2018 |
Dhahri W, Romagnuolo R, Laflamme MA. Training heart tissue to mature. Nature Biomedical Engineering. 2: 351-352. PMID 31011196 DOI: 10.1038/S41551-018-0253-7 |
0.537 |
|
| 2018 |
Hansen KJ, Laflamme MA, Gaudette GR. Development of a Contractile Cardiac Fiber From Pluripotent Stem Cell Derived Cardiomyocytes. Frontiers in Cardiovascular Medicine. 5: 52. PMID 29942806 DOI: 10.3389/Fcvm.2018.00052 |
0.472 |
|
| 2018 |
Romagnuolo R, Masoudpoor H, Porta-Sanchez A, Qiang B, Barry J, Qi X, Masse S, Magtibay K, Laskary A, Wu J, Valdman-Sadikov T, Rothberg J, Titus E, Li R, Zandstra P, ... ... LaFlamme M, et al. REGENERATING THE INFARCTED PIG HEART WITH HUMAN EMBRYONIC STEM CELL-DERIVED CARDIOMYOCYTES INDUCES VENTRICULAR TACHYARRHYTHMIAS Canadian Journal of Cardiology. 34: S140-S141. DOI: 10.1016/J.Cjca.2018.07.196 |
0.589 |
|
| 2018 |
Porta-Sanchez A, Nayyar S, Magtibay K, Masse S, Bhaskaran A, Romagnuolo R, Masoudpoor H, Qiang B, Biswas L, Ghugre N, Keller G, LaFlamme M, Nanthakumar K. CARDIAC REGENERATION WITH HUMAN EMBRYONIC STEM CELL-DERIVED CARDIOMYOCYTES IN INFARCTED SWINE IS ASSOCIATED WITH VENTRICULAR TACHYCARDIA THAT HAS FOCAL PATTERN OF ACTIVATION Canadian Journal of Cardiology. 34: S187-S188. DOI: 10.1016/J.Cjca.2018.07.128 |
0.531 |
|
| 2017 |
Masoudpour H, Laflamme MA. Cardiac repair with pluripotent stem cell-derived cardiomyocytes: Proof of concept but new challenges. The Journal of Thoracic and Cardiovascular Surgery. PMID 28688708 DOI: 10.1016/J.Jtcvs.2017.05.088 |
0.58 |
|
| 2017 |
Smith AST, Yoo H, Yi H, Ahn EH, Lee JH, Shao G, Nagornyak E, Laflamme MA, Murry CE, Kim DH. Micro- and nano-patterned conductive graphene-PEG hybrid scaffolds for cardiac tissue engineering. Chemical Communications (Cambridge, England). PMID 28634611 DOI: 10.1039/C7Cc01988B |
0.395 |
|
| 2017 |
Romagnuolo R, Laflamme MA. Programming cells for cardiac repair. Current Opinion in Biotechnology. 47: 43-50. PMID 28633074 DOI: 10.1016/J.Copbio.2017.05.011 |
0.58 |
|
| 2017 |
Hansen KJ, Favreau JT, Gershlak JR, Laflamme MA, Albrecht DR, Gaudette GR. Optical Method to Quantify Mechanical Contraction and Calcium Transients of Human Pluripotent Stem Cell Derived Cardiomyocytes. Tissue Engineering. Part C, Methods. PMID 28562232 DOI: 10.1089/ten.TEC.2017.0190 |
0.357 |
|
| 2017 |
Dai DF, Danoviz ME, Wiczer B, Laflamme MA, Tian R. Mitochondrial Maturation in Human Pluripotent Stem Cell Derived Cardiomyocytes. Stem Cells International. 2017: 5153625. PMID 28421116 DOI: 10.1155/2017/5153625 |
0.48 |
|
| 2016 |
Smith AS, Macadangdang J, Leung W, Laflamme MA, Kim DH. Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening. Biotechnology Advances. PMID 28007615 DOI: 10.1016/J.Biotechadv.2016.12.002 |
0.473 |
|
| 2015 |
Karabekian Z, Ding H, Stybayeva G, Ivanova I, Muselimyan N, Haque A, Toma I, Posnack NG, Revzin A, Leitenberg D, Laflamme MA, Sarvazyan N. HLA Class I Depleted hESC as a Source of Hypoimmunogenic Cells for Tissue Engineering Applications. Tissue Engineering. Part A. PMID 26218149 DOI: 10.1089/Ten.Tea.2015.0105 |
0.526 |
|
| 2015 |
Hartman ME, Dai DF, Laflamme MA. Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair. Advanced Drug Delivery Reviews. PMID 25980938 DOI: 10.1016/J.Addr.2015.05.004 |
0.616 |
|
| 2015 |
Kuppusamy KT, Jones DC, Sperber H, Madan A, Fischer KA, Rodriguez ML, Pabon L, Zhu WZ, Tulloch NL, Yang X, Sniadecki NJ, Laflamme MA, Ruzzo WL, Murry CE, Ruohola-Baker H. Let-7 family of microRNA is required for maturation and adult-like metabolism in stem cell-derived cardiomyocytes. Proceedings of the National Academy of Sciences of the United States of America. 112: E2785-94. PMID 25964336 DOI: 10.1073/Pnas.1424042112 |
0.485 |
|
| 2015 |
Kadota S, Carey J, Reinecke H, Leggett J, Teichman S, Laflamme MA, Murry CE, Regnier M, Mahairas GG. Ribonucleotide reductase-mediated increase in dATP improves cardiac performance via myosin activation in a large animal model of heart failure. European Journal of Heart Failure. PMID 25876005 DOI: 10.1002/Ejhf.270 |
0.461 |
|
| 2015 |
Posnack NG, Idrees R, Ding H, Jaimes R, Stybayeva G, Karabekian Z, Laflamme MA, Sarvazyan N. Exposure to phthalates affects calcium handling and intercellular connectivity of human stem cell-derived cardiomyocytes. Plos One. 10: e0121927. PMID 25799571 DOI: 10.1371/Journal.Pone.0121927 |
0.368 |
|
| 2014 |
Murry CE, Chong JJ, Laflamme MA. Letter by Murry et al regarding article, "Embryonic stem cell-derived cardiac myocytes are not ready for human trials". Circulation Research. 115: e28-9. PMID 25342771 DOI: 10.1161/Circresaha.114.305042 |
0.572 |
|
| 2014 |
Luo J, Weaver MS, Dennis JE, Whalen E, Laflamme MA, Allen MD. Targeting survival pathways to create infarct-spanning bridges of human embryonic stem cell-derived cardiomyocytes. The Journal of Thoracic and Cardiovascular Surgery. 148: 3180-8.e1. PMID 25227700 DOI: 10.1016/J.Jtcvs.2014.06.087 |
0.574 |
|
| 2014 |
Zhu WZ, Filice D, Palpant NJ, Laflamme MA. Methods for assessing the electromechanical integration of human pluripotent stem cell-derived cardiomyocyte grafts. Methods in Molecular Biology (Clifton, N.J.). 1181: 229-47. PMID 25070341 DOI: 10.1007/978-1-4939-1047-2_20 |
0.647 |
|
| 2014 |
Laflamme M. Introduction to JCPT Focused Issue on "Stem Cells and Cardiac Regenerative Medicine" Journal of Cardiovascular Pharmacology and Therapeutics. 19: 329. PMID 24951120 DOI: 10.1177/1074248414535342 |
0.589 |
|
| 2014 |
Lundy SD, Gantz JA, Pagan CM, Filice D, Laflamme MA. Pluripotent stem cell derived cardiomyocytes for cardiac repair. Current Treatment Options in Cardiovascular Medicine. 16: 319. PMID 24838687 DOI: 10.1007/S11936-014-0319-0 |
0.769 |
|
| 2014 |
Wang G, McCain ML, Yang L, He A, Pasqualini FS, Agarwal A, Yuan H, Jiang D, Zhang D, Zangi L, Geva J, Roberts AE, Ma Q, Ding J, Chen J, ... ... Laflamme MA, et al. Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies. Nature Medicine. 20: 616-23. PMID 24813252 DOI: 10.1038/Nm.3545 |
0.37 |
|
| 2014 |
Lundy SD, Murphy SA, Dupras SK, Dai J, Murry CE, Laflamme MA, Regnier M. Cell-based delivery of dATP via gap junctions enhances cardiac contractility. Journal of Molecular and Cellular Cardiology. 72: 350-9. PMID 24780238 DOI: 10.1016/J.Yjmcc.2014.04.010 |
0.601 |
|
| 2014 |
Chong JJ, Yang X, Don CW, Minami E, Liu YW, Weyers JJ, Mahoney WM, Van Biber B, Cook SM, Palpant NJ, Gantz JA, Fugate JA, Muskheli V, Gough GM, Vogel KW, ... ... Laflamme MA, et al. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature. 510: 273-7. PMID 24776797 DOI: 10.1038/Nature13233 |
0.761 |
|
| 2014 |
Luo J, Weaver MS, Cao B, Dennis JE, Van Biber B, Laflamme MA, Allen MD. Cobalt protoporphyrin pretreatment protects human embryonic stem cell-derived cardiomyocytes from hypoxia/reoxygenation injury in vitro and increases graft size and vascularization in vivo. Stem Cells Translational Medicine. 3: 734-44. PMID 24736402 DOI: 10.5966/Sctm.2013-0189 |
0.594 |
|
| 2014 |
Hartman ME, Liu Y, Zhu WZ, Chien WM, Weldy CS, Fishman GI, Laflamme MA, Chin MT. Myocardial deletion of transcription factor CHF1/Hey2 results in altered myocyte action potential and mild conduction system expansion but does not alter conduction system function or promote spontaneous arrhythmias. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 28: 3007-15. PMID 24687990 DOI: 10.1096/Fj.14-251728 |
0.427 |
|
| 2014 |
Shiba Y, Filice D, Fernandes S, Minami E, Dupras SK, Biber BV, Trinh P, Hirota Y, Gold JD, Viswanathan M, Laflamme MA. Electrical Integration of Human Embryonic Stem Cell-Derived Cardiomyocytes in a Guinea Pig Chronic Infarct Model. Journal of Cardiovascular Pharmacology and Therapeutics. 19: 368-381. PMID 24516260 DOI: 10.1177/1074248413520344 |
0.632 |
|
| 2013 |
Uosaki H, Magadum A, Seo K, Fukushima H, Takeuchi A, Nakagawa Y, Moyes KW, Narazaki G, Kuwahara K, Laflamme M, Matsuoka S, Nakatsuji N, Nakao K, Kwon C, Kass DA, et al. Identification of chemicals inducing cardiomyocyte proliferation in developmental stage-specific manner with pluripotent stem cells. Circulation. Cardiovascular Genetics. 6: 624-33. PMID 24141057 DOI: 10.1161/Circgenetics.113.000330 |
0.551 |
|
| 2013 |
Nunes SS, Miklas JW, Liu J, Aschar-Sobbi R, Xiao Y, Zhang B, Jiang J, Massé S, Gagliardi M, Hsieh A, Thavandiran N, Laflamme MA, Nanthakumar K, Gross GJ, Backx PH, et al. Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nature Methods. 10: 781-7. PMID 23793239 DOI: 10.1038/Nmeth.2524 |
0.55 |
|
| 2013 |
Moyes KW, Sip CG, Obenza W, Yang E, Horst C, Welikson RE, Hauschka SD, Folch A, Laflamme MA. Human embryonic stem cell-derived cardiomyocytes migrate in response to gradients of fibronectin and Wnt5a. Stem Cells and Development. 22: 2315-25. PMID 23517131 DOI: 10.1089/Scd.2012.0586 |
0.553 |
|
| 2013 |
Lundy SD, Zhu WZ, Regnier M, Laflamme MA. Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cells and Development. 22: 1991-2002. PMID 23461462 DOI: 10.1089/Scd.2012.0490 |
0.544 |
|
| 2012 |
Gantz JA, Palpant NJ, Welikson RE, Hauschka SD, Murry CE, Laflamme MA. Targeted genomic integration of a selectable floxed dual fluorescence reporter in human embryonic stem cells. Plos One. 7: e46971. PMID 23071682 DOI: 10.1371/Journal.Pone.0046971 |
0.708 |
|
| 2012 |
Shiba Y, Fernandes S, Zhu WZ, Filice D, Muskheli V, Kim J, Palpant NJ, Gantz J, Moyes KW, Reinecke H, Van Biber B, Dardas T, Mignone JL, Izawa A, Hanna R, ... ... Laflamme MA, et al. Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature. 489: 322-5. PMID 22864415 DOI: 10.1038/Nature11317 |
0.75 |
|
| 2012 |
Banerjee ER, Laflamme MA, Papayannopoulou T, Kahn M, Murry CE, Henderson WR. Human embryonic stem cells differentiated to lung lineage-specific cells ameliorate pulmonary fibrosis in a xenograft transplant mouse model. Plos One. 7: e33165. PMID 22470441 DOI: 10.1371/Journal.Pone.0033165 |
0.489 |
|
| 2012 |
Laflamme MA, Sebastian MM, Buetow BS. Cardiovascular Comparative Anatomy and Histology. 135-153. DOI: 10.1016/B978-0-12-381361-9.00010-X |
0.359 |
|
| 2011 |
Zhu WZ, Van Biber B, Laflamme MA. Methods for the derivation and use of cardiomyocytes from human pluripotent stem cells. Methods in Molecular Biology (Clifton, N.J.). 767: 419-31. PMID 21822893 DOI: 10.1007/978-1-61779-201-4_31 |
0.623 |
|
| 2011 |
Laflamme MA, Murry CE. Heart regeneration. Nature. 473: 326-35. PMID 21593865 DOI: 10.1038/nature10147 |
0.512 |
|
| 2011 |
Xu C, Police S, Hassanipour M, Li Y, Chen Y, Priest C, O'Sullivan C, Laflamme MA, Zhu WZ, Van Biber B, Hegerova L, Yang J, Delavan-Boorsma K, Davies A, Lebkowski J, et al. Efficient generation and cryopreservation of cardiomyocytes derived from human embryonic stem cells. Regenerative Medicine. 6: 53-66. PMID 21175287 DOI: 10.2217/Rme.10.91 |
0.612 |
|
| 2010 |
Fernandes S, Naumova AV, Zhu WZ, Laflamme MA, Gold J, Murry CE. Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats. Journal of Molecular and Cellular Cardiology. 49: 941-9. PMID 20854826 DOI: 10.1016/J.Yjmcc.2010.09.008 |
0.568 |
|
| 2010 |
Madden LR, Mortisen DJ, Sussman EM, Dupras SK, Fugate JA, Cuy JL, Hauch KD, Laflamme MA, Murry CE, Ratner BD. Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proceedings of the National Academy of Sciences of the United States of America. 107: 15211-6. PMID 20696917 DOI: 10.1073/Pnas.1006442107 |
0.443 |
|
| 2010 |
Zhu WZ, Xie Y, Moyes KW, Gold JD, Askari B, Laflamme MA. Neuregulin/ErbB signaling regulates cardiac subtype specification in differentiating human embryonic stem cells. Circulation Research. 107: 776-86. PMID 20671236 DOI: 10.1161/Circresaha.110.223917 |
0.626 |
|
| 2010 |
Chan CK, Rolle MW, Potter-Perigo S, Braun KR, Van Biber BP, Laflamme MA, Murry CE, Wight TN. Differentiation of cardiomyocytes from human embryonic stem cells is accompanied by changes in the extracellular matrix production of versican and hyaluronan. Journal of Cellular Biochemistry. 111: 585-96. PMID 20564236 DOI: 10.1002/Jcb.22744 |
0.476 |
|
| 2010 |
Adler ED, Chen VC, Bystrup A, Kaplan AD, Giovannone S, Briley-Saebo K, Young W, Kattman S, Mani V, Laflamme M, Zhu WZ, Fayad Z, Keller G. The cardiomyocyte lineage is critical for optimization of stem cell therapy in a mouse model of myocardial infarction. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 1073-81. PMID 19940262 DOI: 10.1096/Fj.09-135426 |
0.578 |
|
| 2010 |
Luo J, Van Biber BP, Laflamme MA, Allen MD. HEME OXYGENASE-1 INDUCTION IMPROVES THE SURVIVAL OF HUMAN EMBRYONIC STEM CELL-DERIVED CARDIOMYOCYTE GRAFTS IN VITRO AND IN VIVO Transplantation Journal. 90: 42. DOI: 10.1097/00007890-201007272-00082 |
0.552 |
|
| 2010 |
Lundy SD, Bloemink MJ, Lynn SC, Geeves MA, Laflamme MA, Regnier M. Mechanical and Biochemical Characteristics of Human Stem Cell-Derived Cardiomyocytes Biophysical Journal. 98: 718a. DOI: 10.1016/J.Bpj.2009.12.3935 |
0.495 |
|
| 2009 |
Shiba Y, Hauch KD, Laflamme MA. Cardiac applications for human pluripotent stem cells. Current Pharmaceutical Design. 15: 2791-806. PMID 19689350 DOI: 10.2174/138161209788923804 |
0.668 |
|
| 2009 |
Zhu WZ, Hauch KD, Xu C, Laflamme MA. Human embryonic stem cells and cardiac repair. Transplantation Reviews (Orlando, Fla.). 23: 53-68. PMID 18657407 DOI: 10.1016/J.Trre.2008.05.005 |
0.662 |
|
| 2008 |
Reinecke H, Minami E, Zhu WZ, Laflamme MA. Cardiogenic differentiation and transdifferentiation of progenitor cells. Circulation Research. 103: 1058-71. PMID 18988903 DOI: 10.1161/Circresaha.108.180588 |
0.656 |
|
| 2007 |
Laflamme MA, Zbinden S, Epstein SE, Murry CE. Cell-based therapy for myocardial ischemia and infarction: pathophysiological mechanisms. Annual Review of Pathology. 2: 307-39. PMID 18039102 DOI: 10.1146/Annurev.Pathol.2.010506.092038 |
0.445 |
|
| 2007 |
Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, Reinecke H, Xu C, Hassanipour M, Police S, O'Sullivan C, Collins L, Chen Y, Minami E, Gill EA, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nature Biotechnology. 25: 1015-24. PMID 17721512 DOI: 10.1038/Nbt1327 |
0.58 |
|
| 2007 |
Nussbaum J, Minami E, Laflamme MA, Virag JA, Ware CB, Masino A, Muskheli V, Pabon L, Reinecke H, Murry CE. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 21: 1345-57. PMID 17284483 DOI: 10.1096/Fj.06-6769Com |
0.565 |
|
| 2006 |
Phan BA, Laflamme MA, Stempien-Otero A, Limaye AP, Buckner FS, Levy WC. Confirmation of Chagas' cardiomyopathy following heart transplantation. Heart and Vessels. 21: 325-7. PMID 17151822 DOI: 10.1007/s00380-005-0899-4 |
0.379 |
|
| 2006 |
Minami E, Laflamme MA, Murry CE, Saffitz JE. Response to letter regarding article "extracardiac progenitor cells repopulate most major cell types in the transplanted human heart" [2] Circulation. 113. DOI: 10.1161/Circulationaha.106.613745 |
0.541 |
|
| 2005 |
Minami E, Laflamme MA, Saffitz JE, Murry CE. Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart. Circulation. 112: 2951-8. PMID 16275883 DOI: 10.1161/CIRCULATIONAHA.105.576017 |
0.419 |
|
| 2005 |
McDevitt TC, Laflamme MA, Murry CE. Proliferation of cardiomyocytes derived from human embryonic stem cells is mediated via the IGF/PI 3-kinase/Akt signaling pathway. Journal of Molecular and Cellular Cardiology. 39: 865-73. PMID 16242146 DOI: 10.1016/J.Yjmcc.2005.09.007 |
0.397 |
|
| 2005 |
Laflamme MA, Gold J, Xu C, Hassanipour M, Rosler E, Police S, Muskheli V, Murry CE. Formation of human myocardium in the rat heart from human embryonic stem cells. The American Journal of Pathology. 167: 663-71. PMID 16127147 DOI: 10.1016/S0002-9440(10)62041-X |
0.537 |
|
| 2005 |
Laflamme MA, Murry CE. Regenerating the heart. Nature Biotechnology. 23: 845-56. PMID 16003373 DOI: 10.1038/Nbt1117 |
0.544 |
|
| 2002 |
Laflamme MA, Myerson D, Saffitz JE, Murry CE. Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circulation Research. 90: 634-40. PMID 11934829 DOI: 10.1161/01.Res.0000014822.62629.Eb |
0.475 |
|
| Show low-probability matches. |